Influential inspection test to sleep when going to bed, which depends on presence of "AURAL SONIC panel"

Influential inspection test to sleep when going to bed, which depends on presence of "AURAL SONIC panel" - Influential inspection test to sleep when going to bed, which depends on presence of "AURAL SONIC panel"

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025755

Enrollment

Registered

2017-01-23

Start date

2017-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Using of AURAL SONIC panel(1day) AURAL SONIC panel isn&#39

t used(1day)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: [1]Japanese males and females aged 20-65 years [2]Individuals who are healthy and are not received treatment of disease [3]Individuals with the regular going to bed (turning off the lights) time and wake up time [4]Individuals whose written informed consent has been obtained [5]Individuals judged appropriate for the study by the principal

Exclusion criteria

Exclusion criteria: [1]Individuals using medical products [2]Individuals who are suspected, recived treatment of, or have a history of sleep apnea syndrome [3]Individuals who have or are suspected with the night urination, prostatomegaly, or overactive bladder [4]Individuals who have a history of serious hepatopathy, kidney damage, heart disease and hematological disease [5]Individuals with skin disease, such as atopic dermatitis [6]Individuals who have a history of hepatitis [7]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplyments in the past 3 month or will ingest those foods during the test period [8]Individuals who excessively take alcohol (expressed in an amount of alcohol: over 60mg/day) [9]Individuals who participated in other clinical studies in the past three months [10]Individuals who are or are posslibly, or are lactating [11]Individuals judged inappropriate for the study by the principal

Design outcomes

Primary

Measure	Time frame
6-hydroxymelatonin sulfate; SaMT	—

Countries

Japan

Contacts

Public ContactManabu Fukushima

Nippon Bunri Univ Dep. of Media Technologies

fukushima@nbu.ac.jp097-524-2748

Outcome results